Abstract
Upon intra-abdominal or intravenous injection of allantoic fluids infected with influenza viruses, mice frequently died within 8 to 96 hours. Similar results were observed upon injection of rabbits, rats, and guinea pigs. Autopsy of the mice revealed widespread necrosis of liver and spleen, hemorrhages into the intestines, pleural exudation, and other occasional findings. Survivors frequently developed pulmonary consolidation or jaundice. The dominant type of lesion depended on the strain of virus used. All attempts to demonstrate propagation of the influenza viruses outside of the respiratory tract failed. It was concluded that the early lesions were the result of toxic activities of the virus and not of virus multiplication in the affected tissues. Injection into chick embryos of highly diluted inocula produced higher titers of virus, hemagglutmin, and toxicity in the allantoic fluids than the use of more concentrated seed culture. Serial passage of various strains in high dilution frequently increased the toxic activity. The infectivity often reached its peak in 24 hours when tests for toxicity were still negative. Maximal toxicity was usually not attained before 48 hours. The toxic activity could not be separated from the infective property by such means as differential centrifugation and adsorption onto and elution from chicken red cells. However, upon heating, formalinization, and irradiation with ultraviolet light, the ability of the agents to propagate was lost at a faster rate than the toxic property. The toxic property remained stable for 2 to 3 months at 4°C. This stability was comparable to that of the infectivity for chick embryos. Specific immune sera neutralized in high dilution the toxic activity of the homologous virus. Non-specific neutralization occurred in low dilutions of normal and heterologous immune sera. Strain differences were indicated by this method of testing. Vaccination of mice by the subcutaneous or intra-abdominal routes protected mice specifically against the toxic effects of intra-abdominally or intravenously injected preparations of virus.
Full Text
The Full Text of this article is available as a PDF (1.3 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chambers L. A., Henle W., Lauffer M. A., Anderson T. F. STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA A. J Exp Med. 1943 Mar 1;77(3):265–276. doi: 10.1084/jem.77.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delbrück M. Interference Between Bacterial Viruses: III. The Mutual Exclusion Effect and the Depressor Effect. J Bacteriol. 1945 Aug;50(2):151–170. [PMC free article] [PubMed] [Google Scholar]
- Francis T., Jr, Salk J. E. A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS. Science. 1942 Nov 27;96(2500):499–500. doi: 10.1126/science.96.2500.499. [DOI] [PubMed] [Google Scholar]
- Francis T., Moore A. E. A STUDY OF THE NEUROTROPIC TENDENCY IN STRAINS OF THE VIRUS OF EPIDEMIC INFLUENZA. J Exp Med. 1940 Nov 30;72(6):717–728. doi: 10.1084/jem.72.6.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedewald W. F. ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES. J Exp Med. 1944 Dec 1;80(6):477–491. doi: 10.1084/jem.80.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godfried E. G. Clinical tests for bilirubin in urine. Biochem J. 1934;28(6):2056–2060. doi: 10.1042/bj0282056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henle W., Chambers L. A., Groupé V. THE SEROLOGICAL SPECIFICITY OF PARTICULATE COMPONENTS DERIVED FROM VARIOUS NORMAL MAMMALIAN ORGANS. J Exp Med. 1941 Oct 31;74(5):495–510. doi: 10.1084/jem.74.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henle W., Henle G. THE TOXICITY OF INFLUENZA VIRUSES. Science. 1945 Oct 19;102(2651):398–400. doi: 10.1126/science.102.2651.398. [DOI] [PubMed] [Google Scholar]
- Hirst G. K. ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS. J Exp Med. 1942 Aug 1;76(2):195–209. doi: 10.1084/jem.76.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orcutt M. L., Shope R. E. THE DISTRIBUTION OF SWINE INFLUENZA VIRUS IN SWINE. J Exp Med. 1935 Nov 30;62(6):823–826. doi: 10.1084/jem.62.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rake G., Jones H. P. STUDIES ON LYMPHOGRANULOMA VENEREUM : II. THE ASSOCIATION OF SPECIFIC TOXINS WITH AGENTS OF THE LYMPHOGRANULOMA-PSITTACOSIS GROUP. J Exp Med. 1944 May 1;79(5):463–486. doi: 10.1084/jem.79.5.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rickard E. R., Francis T. THE DEMONSTRATION OF LESIONS AND VIRUS IN THE LUNGS OF MICE RECEIVING LARGE INTRA-PERITONEAL INOCULATIONS OF EPIDEMIC INFLUENZA VIRUS. J Exp Med. 1938 May 31;67(6):953–972. doi: 10.1084/jem.67.6.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salk J. E., Lavin G. I., Francis T. THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION. J Exp Med. 1940 Nov 30;72(6):729–745. doi: 10.1084/jem.72.6.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woolpert O. C., Gallagher F. W., Rubinstein L., Hudson N. P. PROPAGATION OF THE VIRUS OF HUMAN INFLUENZA IN THE GUINEA PIG FETUS. J Exp Med. 1938 Aug 31;68(3):313–324. doi: 10.1084/jem.68.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]